Heli M Lahtela1, Aissa Bah2, Tuomas Kiviniemi3, Wail Nammas4, Axel Schlitt5, Andrea Rubboli6, Pasi P Karjalainen4, Marco Proietti7, Juha E K Hartikainen2, Gregory Y H Lip7,8, K E Juhani Airaksinen3. 1. Emergency Department, North-Kymi Hospital, Kouvola, Finland. 2. Heart Center, Kuopio University Hospital and University of Kuopio, Kuopio, Finland. 3. Heart Center, Turku University Hospital and University of Turku, Turku, Finland. 4. Heart Center, Satakunta Central Hospital, Pori, Finland. 5. Medical Faculty, Martin Luther University Halle, Germany, and Department of Cardiology, Paracelsus Harz-Clinic, Bad Suderode, Germany. 6. Division of Cardiology, Laboratory of Interventional Cardiology, Ospedale Maggiore, Bologna, Italy. 7. University of Birmingham Institute of Cardiovascular Sciences, City Hospital, Birmingham, United Kingdom. 8. Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Abstract
BACKGROUND: More evidence is needed on the optimal antithrombotic regimen in elderly patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI). HYPOTHESIS: Octogenarian patients (aged ≥80 years) with AF who underwent PCI have worse 12-month clinical outcome, compared with younger patients. METHODS: We performed a post-hoc analysis of data from the prospective, multicenter AFCAS registry, which enrolled consecutive patients with AF who underwent PCI and stenting. Outcome measures included major adverse cardiac/cerebrovascular events (MACCE; all-cause death, myocardial infarction, repeat revascularization, stent thrombosis, or stroke/transient ischemic attack) and bleeding events at 12-month follow-up. RESULTS: Out of 925 AF patients enrolled in AFCAS registry, 195 (21.1%) were ≥80 years. Mean age was 82.9 ± 2.6 years; 41.5% were women; 32.3% had diabetes mellitus. Compared with patients aged <80 years, there were more females among the octogenarians (P < 0.001). Compared with younger patients, octogenarians smoked and had dyslipidemia less often, and presented more frequently with acute coronary syndrome. The frequency and duration of antithrombotic regimens prescribed at discharge were comparable. At 12-month follow-up, overall MACCE rate was higher in octogenarians compared with younger patients (27.7% vs 20.1%, P = 0.02). The rate of acute myocardial infarction was higher in octogenarians (9.2% vs 4.9%, P = 0.02), but the rates of all bleeds and BARC >2 bleeds were similar (P = 0.13, P = 0.29, respectively). CONCLUSIONS: In real-world patients with AF undergoing PCI, patients aged ≥80 years had higher incidence of MACCE at 12-month follow-up compared with younger patients, although they received comparable antithrombotic treatment. The rates of bleeding events were similar.
BACKGROUND: More evidence is needed on the optimal antithrombotic regimen in elderly patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI). HYPOTHESIS: Octogenarian patients (aged ≥80 years) with AF who underwent PCI have worse 12-month clinical outcome, compared with younger patients. METHODS: We performed a post-hoc analysis of data from the prospective, multicenter AFCAS registry, which enrolled consecutive patients with AF who underwent PCI and stenting. Outcome measures included major adverse cardiac/cerebrovascular events (MACCE; all-cause death, myocardial infarction, repeat revascularization, stent thrombosis, or stroke/transient ischemic attack) and bleeding events at 12-month follow-up. RESULTS: Out of 925 AFpatients enrolled in AFCAS registry, 195 (21.1%) were ≥80 years. Mean age was 82.9 ± 2.6 years; 41.5% were women; 32.3% had diabetes mellitus. Compared with patients aged <80 years, there were more females among the octogenarians (P < 0.001). Compared with younger patients, octogenarians smoked and had dyslipidemia less often, and presented more frequently with acute coronary syndrome. The frequency and duration of antithrombotic regimens prescribed at discharge were comparable. At 12-month follow-up, overall MACCE rate was higher in octogenarians compared with younger patients (27.7% vs 20.1%, P = 0.02). The rate of acute myocardial infarction was higher in octogenarians (9.2% vs 4.9%, P = 0.02), but the rates of all bleeds and BARC >2 bleeds were similar (P = 0.13, P = 0.29, respectively). CONCLUSIONS: In real-world patients with AF undergoing PCI, patients aged ≥80 years had higher incidence of MACCE at 12-month follow-up compared with younger patients, although they received comparable antithrombotic treatment. The rates of bleeding events were similar.
Authors: Kevin C Floyd; John E Jayne; Aaron V Kaplan; Bruce J Friedman; Nathaniel W Niles; Bruce D Hettleman; John F Robb; Craig A Thompson Journal: J Interv Cardiol Date: 2006-10 Impact factor: 2.279
Authors: Donald E Cutlip; Stephan Windecker; Roxana Mehran; Ashley Boam; David J Cohen; Gerrit-Anne van Es; P Gabriel Steg; Marie-angèle Morel; Laura Mauri; Pascal Vranckx; Eugene McFadden; Alexandra Lansky; Martial Hamon; Mitchell W Krucoff; Patrick W Serruys Journal: Circulation Date: 2007-05-01 Impact factor: 29.690
Authors: Paulus Kirchhof; Stefano Benussi; Dipak Kotecha; Anders Ahlsson; Dan Atar; Barbara Casadei; Manuel Castella; Hans-Christoph Diener; Hein Heidbuchel; Jeroen Hendriks; Gerhard Hindricks; Antonis S Manolis; Jonas Oldgren; Bogdan Alexandru Popescu; Ulrich Schotten; Bart Van Putte; Panagiotis Vardas Journal: Eur Heart J Date: 2016-08-27 Impact factor: 29.983
Authors: Andrea Rubboli; Jonathan L Halperin; K E Juhani Airaksinen; Michael Buerke; Eric Eeckhout; Saul B Freedman; Anthony H Gershlick; Axel Schlitt; Hung Fat Tse; Freek W A Verheugt; Gregory Y H Lip Journal: Ann Med Date: 2008 Impact factor: 4.709
Authors: Jan Heeringa; Deirdre A M van der Kuip; Albert Hofman; Jan A Kors; Gerard van Herpen; Bruno H Ch Stricker; Theo Stijnen; Gregory Y H Lip; Jacqueline C M Witteman Journal: Eur Heart J Date: 2006-03-09 Impact factor: 29.983
Authors: C Michael Gibson; Roxana Mehran; Christoph Bode; Jonathan Halperin; Freek W Verheugt; Peter Wildgoose; Mary Birmingham; Juliana Ianus; Paul Burton; Martin van Eickels; Serge Korjian; Yazan Daaboul; Gregory Y H Lip; Marc Cohen; Steen Husted; Eric D Peterson; Keith A Fox Journal: N Engl J Med Date: 2016-11-14 Impact factor: 91.245
Authors: Daniel I Bromage; Daniel A Jones; Krishnaraj S Rathod; Claire Grout; M Bilal Iqbal; Pitt Lim; Ajay Jain; Sundeep S Kalra; Tom Crake; Zoe Astroulakis; Mick Ozkor; Roby D Rakhit; Charles J Knight; Miles C Dalby; Iqbal S Malik; Anthony Mathur; Simon Redwood; Philip A MacCarthy; Andrew Wragg Journal: J Am Heart Assoc Date: 2016-06-27 Impact factor: 5.501
Authors: Heli M Lahtela; Aissa Bah; Tuomas Kiviniemi; Wail Nammas; Axel Schlitt; Andrea Rubboli; Pasi P Karjalainen; Marco Proietti; Juha E K Hartikainen; Gregory Y H Lip; K E Juhani Airaksinen Journal: Clin Cardiol Date: 2017-12-15 Impact factor: 2.882